Home›Companies›Biotech & Pharma›Balto Pharmaceuticals

Balto Pharmaceuticals, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 14, 2023·Suggest an edit

About Balto Pharmaceuticals

Balto Pharmaceuticals is a private company based in South Pasadena, California. It has reported $2,000,000 raised in one offering on Form D since September 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 22, 2023Sep 14, 2023$2,000,000fully sold2$1.0MEquityRule 504, Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Balto Pharmaceuticals's Form D filed Sep 14, 2023.

Sources

  1. SECBalto Pharmaceuticals, Inc. filing history